Tagged blood cancer

Amgen develops Myeloma blood cancer drug that outperforms rival Velcade in study

Mar 2, 2015

Amgen, Inc. is forging forward with its Kyprolis cancer therapy, which according to an interim analysis enabled patients with relapsed multiple myeloma live twice as long before their blood cancer worsened. The...

FDA approves Jakafi for the treatment of a dangerous blood disorder

Siddhant Ghatge

Dec 6, 2014

The US Food and Drug Administration have approved Incyte Corporation’s Jakafi. Jakafi has been the first drug that has been approved for the disease and will now be used to treat patients with polycythemia vera...